Clinical Trial Update: The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis [Phase 1]

View source ↗

Summary

This clinical trial update describes the safety and preliminary efficacy of the investigational drug S103 in adults with refractory generalized myasthenia gravi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• S103

Snippet

Sponsor: Ting Chang, MD | Conditions: Myasthenia Gravis, Generalized | Phase 1 | Status: NOT_YET_RECRUITING